As Cannabis Use Grows Among Cancer Patients, Federal Agency Highlights Need For Rescheduling
As cannabis legalization continues to expand across the U.S., its use among cancer patients has also increased significantly, particularly for managing symptoms like nausea, pain, anxiety and insomnia.
A recent blog entry from Carmen Phillips at the National Cancer Institute (NCI), a part of the National Institute of Health (NIH), underscores the growing demand for more robust scientific research on cannabis, especially as more cancer patients turn to it as a form of relief.
Oncologists call attention to the urgent need to reschedule cannabis to facilitate further research and fill “the Cannabis-and-Cancer Information Gap”.
Rising Cannabis Use Among Cancer Patients
Recent studies estimate that between 20% to 40% of cancer patients use cannabis or cannabinoids to manage side effects from both the disease and its treatment. With 38 states having legalized medical marijuana, patients are finding it easier than ever to access products.
Dr. Richard T. Lee, who …